Rossari Biotech posts Q4 FY24 consolidated PAT at Rs. 34.13 Cr

Rossari Biotech posts Q4 FY24 consolidated PAT at Rs. 34.13 Cr

By: ICN Bureau

Last updated : April 30, 2024 9:27 am



The company has reported total income of Rs. 473.105 crores during the period ended March 31, 2024


Rossari Biotech Limited has reported Consolidated financial results for the period ended March 31, 2024.

Rossari Biotech has posted net profit of Rs. 34.13 crores for the period ended March 31, 2024 as against net profit of Rs. 34.39 crores for the period ended December 31, 2023. The company posted net profit of Rs.28.97 crores for the period ended March 31, 2023.

The company has reported total income of Rs. 473.105 crores during the period ended March 31, 2024 as compared to Rs. 467.271 crores during the period ended December 31, 2023. The company reported total income of Rs.409.27 crores during the period ended March 31, 2023.

For the Financial Year ended March 31, 2024, Rossari Biotech has reported total income of Rs. 1,838 crores as compared to Rs. 1,661.365 crores during the Financial Year ended March 31, 2023.

The company has posted net profit of Rs.130.68 crores for the Financial Year ended March 31, 2024 as against net profit of Rs.107.25 crores for the Financial Year ended March 31, 2023.

Rossari Biotech Limited

First Published : April 30, 2024 12:00 am